A phenotypic screening platform utilising human spermatozoa identifies compounds with contraceptive activity.

Abstract excerpt

There is an urgent need to develop new methods for male contraception, however a major barrier to drug discovery has been the lack of validated targets and the absence of an effective high-throughput phenotypic screening system. To address this deficit, we developed a fully-automated robotic screening platform that provided quantitative evaluation of compound activity against two key attributes of human sperm...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Discovery
• Share to High-Throughput Screening Assays